RankAlpha logo
Back to Rankings

IBRX

ImmunityBioC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
IBRX vs peer average
50/100
IBRX vs. peer average (C vs. C)
Grade spread
A 1 · C 7 · D 2
Graded peers loaded
Coverage
10 graded
91% of tracked

Peer overview

AUPH is the first available peer comparator.

Closest size-matched commercial biopharma comparator in the packet; useful for judging whether IBRX can convert a single marketed specialty asset into durable revenue and narrower financing risk.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAUPHAurinia
IBRX
ImmunityBio
AUPH
Aurinia
Grade
C
C
Momentum
88
28
Value
41
66
Sentiment
42
53
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs AUPH

IBRX / AUPH
Grade Position
In line
IBRX vs. peer average (C vs. C)
50/100
Momentum
88
IBRX
Value
41
AUPH
Sentiment
42
AUPH

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IBRX
1
AUPH
AUPH
C
60/100
Even
2
GLPG
GLPG
-
-
-
3
REGN
REGN
C
60/100
Even
4
PCVX
Vaxcyte Inc Common
C
60/100
Even
5
QGEN
QIAGEN NV Common
C
60/100
Even
AUPH is the first peer returned for this comparison set.